临床试验/NCT00543894

NCT00543894已完成不适用

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A Prospective, Observational, Multicenter Study (ANTHICUS)

AstraZeneca0 个研究点目标入组 500 人开始时间: 2006年2月最近更新: 2008年8月12日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: AstraZeneca
入组人数: 500

研究概览研究设计入排标准研究者记录与标识符相似试验

研究概览

简要总结

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A prospective, observational, multicenter study (ANTHICUS).

研究设计

研究类型: Observational
时间视角: Prospective

入排标准

接受健康志愿者: 否

入选标准

•Patients with hospital-acquired infections and hospitalised in the ICU at one moment of their hospital stay
•Hospital-acquired infections accounting for eligibility are:
•nosocomial pneumonia (including ventilator-associated pneumonia)
•bacteremia
•intra-abdominal infections
•urosepsis

排除标准

未提供

研究者

发起方

申办方类型

Industry

相似试验

Impact of Rapid Molecular Diagnostic Method on Antibiotics Exposure Duration in ICU Patients with Postoperative PeritonitisPostoperative Peritonitis

NCT04925388Assistance Publique - Hôpitaux de Paris16

Study of Antibiotic Utilization Measures and Control of ESBLs in ChinaICU Patient

NCT00488813Wyeth is now a wholly owned subsidiary of Pfizer300

An Epidemiological Study on Antimicrobial Treatment of Nosocomial Infections in Clinical PracticeNosocomial Infection

NCT00864929AstraZeneca1,500

Antibiotic Treatment in Ventilator Associated Tracheobronchitis (VAT)Tracheobronchitis

NCT01027832Assaf-Harofeh Medical Center100

Trends in inpatient antimicrobial use and appropriateness of antimicrobial therapy from 2018 to 2019: a single-center point prevalence survey.Infectious disease

JPRN-UMIN000037720ational Hospital Organization Tochigi Medical Center275